ALGS - Aligos Therapeutics GAAP EPS of -$0.44 beats by $0.14 revenue of $4.12M beats by $3.37M November, 02 2022 04:51 PM Aligos Therapeutics Inc. Aligos Therapeutics press release ( NASDAQ: ALGS ): Q3 GAAP EPS of -$0.44 beats by $0.14 . Revenue of $4.12M beats by $3.37M . For further details see: Aligos Therapeutics GAAP EPS of -$0.44 beats by $0.14, revenue of $4.12M beats by $3.37M